Global MRI-Guided Neurosurgical Ablation Market

Global MRI-Guided Neurosurgical Ablation Market Size, Share, Growth Analysis, By Product(MRI Guided RF Ablation Systems, MRI Guided Laser Ablation Systems), By End-use(Hospitals, Clinics and Ambulatory Surgical Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35H2181 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 62 | Figures: 76

Global MRI-Guided Neurosurgical Ablation Market News

  • In February 2022, the U.S. Food and Drug Administration (FDA) approved Medtronic plc for InterStim X, a device that offers sacral neuromodulation therapy. Notably, this approval is significant as the device boasts an extended battery life of 10 years, promising patients greater convenience and reduced maintenance requirements.
  • In March 2022, Medtronic plc established a collaborative partnership with Vizient to introduce Touch Surgery Enterprise, an AI-powered solution. This innovative technology is designed to streamline the tasks of analyzing, documenting, and sharing surgical videos, ultimately enhancing the performance of surgeons.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global MRI-Guided Neurosurgical Ablation Market size was valued at USD 566.92 million in 2021 and is poised to grow from USD 608.31 million in 2022 to USD 1068.86 million by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

The market competitive landscape for neurosurgical ablation guided by magnetic resonance imaging (MRI) offers information fragmented down by intranet. In-depth information is provided about the product launch, product width and breadth, application dominance, new market initiatives, company strengths, weaknesses, production facilities and sites, production capacities, R&D spending, finances, and Revenue. 'Medtronic', 'InSightec Ltd.', 'Elekta AB', 'Monteris Medical', 'Profound Medical', 'Boston Scientific Corporation', 'MR Solutions', 'MRI Interventions, Inc.', 'Varian Medical Systems', 'AngioDynamics', 'Abbott Laboratories', 'Hitachi Medical Systems', 'Siemens Healthineers', 'IMRIS, Deerfield Imaging', 'Accuray Incorporated', 'Perseon Corporation', 'Elekta AB', 'Isacord', 'Monteris Medical', 'Focal Therapeutics', 'Shamrad Electronics'

The demand is mostly driven by the increased prevalence of neurological conditions. Numerous diseases impact the nervous system, which are characterized as neurological disorders. Some of these disorders have the potential to be fatal or extremely disabling. Innovative therapeutic methods like MRI-guided neurosurgical ablation are becoming more popular.

Patient-centric care is an essential trend in the MRI-guided neurosurgical ablation market, emphasizing a personalized approach to treatment. This patient-centered model places the individual at the heart of decision-making, since their exclusive needs and preferences. In the context of MRI-guided ablation, patient-centric care interprets into adapting procedures to the specific condition and characteristics of each patient. This approach not only arranges minimally invasive, exact treatments but also encourages collective decision-making, safeguarding that patients are active participants in their healthcare journey. As a result, patient-centric care improves the overall experience, encourages positive outcomes, and aligns with the broader shift towards more adapted and responsive healthcare services in neurosurgery.

North America held a 34.6% market share. This is illuminated by the region's well-established healthcare facilities, the rising prevalence of brain tumors and malignancies, and the convenience of highly qualified neurosurgeons. The market for North America is primarily driven by the rising incidence of detailed disorders including brain tumors, most of which are malignant, and neurodegenerative diseases. Additionally, the market expansion in the area is being supported by the incidence of significant important players. Thus, the primary factors driving the market are the increasing number of minimally invasive neurosurgery procedures and the rising incidence of neurological diseases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global MRI-Guided Neurosurgical Ablation Market

Report ID: UCMIG35H2226 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Artificial Intelligence in Genomics Market
Buy Now GET FREE SAMPLE
Global MRI-Guided Neurosurgical Ablation Market

Report ID: UCMIR35H2267 | Region: Regional | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

U.S. Platelet Rich Plasma Market
Buy Now GET FREE SAMPLE
Global MRI-Guided Neurosurgical Ablation Market

Report ID: UCMIG35H2152 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Microbial Fermentation Technology Market
Buy Now GET FREE SAMPLE
Global MRI-Guided Neurosurgical Ablation Market

Report ID: UCMIG35H2135 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: Figures:

Cloning And Mutagenesis Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global MRI-Guided Neurosurgical Ablation Market

Product ID: SQMIG35H2181

$5,300
BUY NOW GET FREE SAMPLE